CREFX | NREAX | CREFX / NREAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 15 years | - |
Gain YTD | 0.811 | 0.143 | 565% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.66B | 712M | 1,076% |
Annual Yield % from dividends | 3.03 | 1.97 | 154% |
Returns for 1 year | 11.50 | 10.11 | 114% |
Returns for 3 years | -7.99 | -17.71 | 45% |
Returns for 5 years | 11.90 | 1.73 | 690% |
Returns for 10 years | N/A | 5.85 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCTIX | 48.57 | 0.42 | +0.87% |
Goldman Sachs US Tax-Managed Eq Instl | |||
GSSIX | 41.69 | 0.25 | +0.60% |
Goldman Sachs Small Cap Value Inst | |||
GSXIX | 42.43 | 0.25 | +0.59% |
abrdn US Small Cap Equity Inst Svc | |||
FFFMX | 56.35 | 0.29 | +0.52% |
American Funds American Mutual 529-F-3 | |||
RYOIX | 64.68 | -0.08 | -0.12% |
Rydex Biotechnology Inv |